Literature DB >> 125005

[Morbus Hodgkin in autopsies today (author's transl)].

E Grundmann, R Fritzsche.   

Abstract

In Hodgkin's disease, good clinical results are obtained by the modern combined treatment with irradiation and chemotherapy. An examination of autopsy findings show in the period 1955-1964 a mean survival time (measured from first biopsy until death) of 22 month, in the period 1965-1973 of 42 month. In contrast to first biopsies, autopsies have a prevalence to the reticular "Hodgkin-sarcoma" .41% of all cases are of this type. 12 of these cases had changed from the lymphocytic predominaut type or from nodular sclerosis, to the reticular type. This augmentation of the reticular type is seen as a consequence of modern therapy. In 18 autopsies, histologic classification was rendered impossible by massive scarring. 8 cases of the period 1965-1973 did not show any lymphogranulomatous tissue and could be morphologically defined as "cured". Therapeutic damages were found in 15 cases. 6 cases had diffuse pulmonary fibrosis. The therapy provoked scars could be differentiated histologically from the hyalinizations occurring in nodular sclerosis and in diffuse fibrosis.

Entities:  

Mesh:

Year:  1975        PMID: 125005     DOI: 10.1007/bf00284398

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  31 in total

1.  The liver in Hodgkin's disease.

Authors:  R LEVITAN; H D DIAMOND; L F CRAVER
Journal:  Gut       Date:  1961-03       Impact factor: 23.059

2.  [Transition from lymphogranulomatosis to sarcoma caused by drug therapy].

Authors:  W JANSSEN; G WUST
Journal:  Munch Med Wochenschr       Date:  1956-10-12

Review 3.  [Staging in malignant lymphoma. Equally a contribution to the significance of laparotomy with splenectomy (author's transl)].

Authors:  K Musshoff; J Slanina
Journal:  Klin Wochenschr       Date:  1974-02-01

4.  Hodgkin's disease. A clinical and pathologic study of 235 cases.

Authors:  A S Patchefsky; H Brodovsky; M Southard; H Menduke; S Gray; W S Hoch
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

5.  [Advances in drug therapy of neoplasms].

Authors:  R Gross
Journal:  Verh Dtsch Ges Inn Med       Date:  1972

6.  Relationship of histological findings to survival in Hodgkin's disease.

Authors:  J J Butler
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  The need for a new clinical classification in Hodgkin's disease: keynote address.

Authors:  M V Peters
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

8.  [Histological classification of Hodgkin's malignant lymphoma and its importance for prognosis].

Authors:  W Hamann; W Oehlert; E Musshoff; A Nuss; B Schnellbacher
Journal:  Dtsch Med Wochenschr       Date:  1970-01-16       Impact factor: 0.628

9.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

10.  Further observations on the biologic significance of vascular invasion in Hodgkin's disease.

Authors:  S B Strum; G B Hutchison; J K Park; H Rappaport
Journal:  Cancer       Date:  1971-01       Impact factor: 6.860

View more
  1 in total

1.  [The significance of histologic assessment of the bone marrow in Hodgkin's disease].

Authors:  R Bartl; R Burkhardt; H Lengsfeld; D Huhn
Journal:  Klin Wochenschr       Date:  1976-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.